We read with great interest the manuscript of Rivero et al1 about the treatment of a recurrent in-stent restenosis (R-ISR) treated by bioresorbable vascular scaffold (BVS) implantation followed by a subacute stent thrombosis due to a subacute BVS recoil.
BVS implantation in a diabetic patient with R-ISR (due to a primitive severe calcific lesion) is an interesting treatment choice option, even if it has not been described sufficiently before in the literature and is not contemplated at the moment for this device.
BVS struts present a thickness of 157 μm, almost double that of second-generation drug-eluting stents (DES) ...
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com